Michele Freesmeier

Exceptional responses with sequential metronomic temozolomide after pembrolizumab failure in patients with metastatic melanoma.

Y. Zakharia, U. Swami, A. Bossler, 2019, Melanoma research.

Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study

Marion Vanneste, Y. Zakharia, U. Swami, 2017, Oncotarget.

1265 Vedolizumab plus anti-PD1 antibody in advanced melanoma patients with inflammatory enterocolitis

Y. Zakharia, M. Milhem, Asad Javed, 2022, Regular and Young Investigator Award Abstracts.

Adhering to the guidelines: rates of BRCA mutation using NCCN genetic testing criteria

Jaime, Shaheen, J. Kirkwood, 2017 .

The effect of weight-based chemotherapy dosing in a cohort of gynecologic oncology patients.

M. Goodheart, A. Button, D. Bender, 2013, Gynecologic oncology.